VisEn, founded in 2005, was an in vivo imaging technology company focused on proprietary molecular imaging systems and reagents for cancer, cardiovascular, skeletal and pulmonary applications. The company was acquired by PerkinElmer in 2010.
Latest Press from VisEn Medical
- VisEn Launches New Gastrosense™ 750 Fluorescence Imaging Agent 04.25.2010
- VisEn Launches New VivoTag® 680 XL Fluorescence Molecular Imaging Label 03.11.2010
- VisEn Acquires Key Fluorescence Agent Intellectual Property Portfolio and Technology Platforms from Bayer Schering Pharma 01.28.2010
- VisEn Launches New Cat B 680 FAST™ Fluorescence Molecular Imaging Agent 01.19.2010
- VisEn Launches New Osteosense® 800 and Vivotag® 800 Fluorescence Molecular Imaging Agents 11.19.2009
- VisEn Launches New Cat B 750 FAST™ Fluorescence Molecular Imaging Agent at American Heart Association Meeting 11.12.2009